optimized to bring transformational products to marketRonald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.”
With the merger completed and capacity to bring transformational products to market AEZS could enter a partnership with a global company or companies whose strength is marketing. AEZS has the human technical capacity and resources to develop transformation products to market. The partner can take care of marketing. A deal with a global marketing partner for PGX-YBG as an immune booster and PGX-YBG/CoQ10 where AEZS develops products through clinical trials could be interesting. AEZS could also control the Canadian marketing opportunity and with PGX-YBG as an immune booster, and PGX-YBG/CoQ10, and Juvente, and the chewy product have critical mass to support a Canadian sales team. Ronnie Miller ran the Canadian division of Roche.
News release:
"This next phase of scale up will allow us to work with commercial partners in nutraceuticals and pharmaceuticals to formulate, test, and commercialize novel products and formulations, including novel functional foods and beverages, novel drugs and various forms of delivery systems,” said Gilles Gagnon, M.Sc., MBA, President and CEO."